Algo version: 0.98b
Kaken Pharmaceutical Co., is listed at the JPX Exchange
Kaken Pharmaceutical Co., [4521.T]
JPX Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Kaken Pharmaceutical Co., stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Kaken Pharmaceutical Co., pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY115 per share. Over the last 48 times between 2001 and 2024, Kaken Pharmaceutical Co., has paid JPY1735.5 with an average of JPY36.16 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Kaken Pharmaceutical Co., 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY5 080.00, you would have made a loss of JPY-1 017.00 per share or -20.02%

Yes, the average daily trading liquidity for Kaken Pharmaceutical Co., is JPY141 244 thousand. You should therefore be able to get in and out of your positions relatively fast.

Kaken Pharmaceutical Co., has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.08, the company's ability to pay off the debt is good. Kaken Pharmaceutical Co., has a good net profit margin of 11.14% and should have high tolerances against inflation.

We have calculated the inflation risk for Kaken Pharmaceutical Co., to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.